Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Changi General Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Singapore and Australia registers with Changi General Hospital as lead sponsor. Synced 12 Nov 2026
13Current trials
8Recruiting now
0Drugs in these trials
2Trial registers
At a glance

Changi General Hospital is the lead sponsor of 13 current clinical trials in our Singapore and Australia registers. 8 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Hypertension.

ClinicalTrials.gov trials by status

  • Recruiting862%
  • Not yet open215%
  • Active, closed18%
  • By invitation215%

Trials by phase

  • Not applicable862%
  • Observational538%
01

Clinical trials sponsored by Changi General Hospital

13 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
A Randomized Controlled Trial Comparing Whole Body Vibration Therapy With Usual Care and Usual Care to Improve Muscle Health in Older Adults
NCT07205133 · ClinicalTrials.gov ↗ · Aging, Frailty, Sarcopenia
Not applicable Recruiting 2026-01 Singapore
A Single-arm, Open-label Clinical Trial to Evaluate the Effect of SMT04 in Irritable Bowel Syndrome (IBS)
NCT06636513 · ClinicalTrials.gov ↗ · Irritable Bowel Syndrome
Not applicable Recruiting 2024-03 Singapore
Addressing Medication Non-adherence in Patients With Poorly Controlled Hypertension Using Urine Mass Spectrometry
NCT06938633 · ClinicalTrials.gov ↗ · Hypertension, Uncontrolled Hypertension, Non-Adherence, Medication
Not applicable Recruiting 2024-02 Singapore
OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities
NCT06890169 · ClinicalTrials.gov ↗ · Obesity and Type 2 Diabetes, NAFLD - Non-Alcoholic Fatty Liver Disease, Hypertension
Not applicable Recruiting 2025-05 Singapore
Breast Cancer Rehabilitation Needs and Service Uptake
NCT06753357 · ClinicalTrials.gov ↗ · Breast Cancer, Cancer Survivorship, Health Attitude
Observational Recruiting 2026-05 Singapore
Gut Microbiome and Metabolome in Patients With Gallstone Disease After Surgical and Endoscopic Interventions
NCT05689255 · ClinicalTrials.gov ↗ · Gallstone Disease, Bile Duct Diseases
Observational Recruiting 2022-12 Singapore
Feasibility, Safety and Efficacy of a Predominantly Plant-based Diet in an Asian Population With Chronic Kidney Disease
NCT07544524 · ClinicalTrials.gov ↗ · Chronic Kidney Disease stage3, Chronic Kidney Disease stage4, Diet Habit
Not applicable Recruiting 2026-04 Singapore
Trial of Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism (TARGET-PA)
NCT07297745 · ClinicalTrials.gov ↗ · Hyperaldosteronism; Primary, Primary Aldosteronism Due to Aldosterone Producing Adenoma
Not applicable Recruiting 2026-01 Singapore
Concurrent Trials on Nature-Based Therapy for Inpatients in Dementia and Rehabilitation Medicine Wards
NCT07059390 · ClinicalTrials.gov ↗ · Dementia, Acquired Brain Injury Including Stroke
Not applicable Not yet open 2027-05 Singapore
Programmable Smart Watch for Remote Pre-habilitation/Rehabilitation Monitoring
NCT06970717 · ClinicalTrials.gov ↗ · Rehabilitation Exercise
Not applicable Not yet open 2025-06 Singapore
Model Development and Temporal Validation of the Predictive Factors for Return to Work After Stroke Rehabilitation
NCT06842420 · ClinicalTrials.gov ↗ · Stroke
Observational By invitation 2023-10 Singapore
Implementation Research on the LILAC Method to Educate Management of Elevated Lipoprotein(a).
NCT07177612 · ClinicalTrials.gov ↗ · Lipoprotein(a), Lipoprotein(a), Hyper-Lp(a)-Emia
Observational By invitation 2025-09 Singapore, Australia
Elevated Lipoprotein(a) in Hospital Staff
NCT06304415 · ClinicalTrials.gov ↗ · Hypercholesterolemia, Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia, Cardiovascular Diseases
Observational Active, closed 2024-04 Singapore

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Changi General Hospital trials

30 conditions
Hypertension2Aging1Frailty1Sarcopenia1Muscle Strength1Dementia1Acquired Brain Injury Including Stroke1Irritable Bowel Syndrome1Stroke1Uncontrolled Hypertension1Non-Adherence, Medication1Obesity and Type 2 Diabetes1NAFLD - Non-Alcoholic Fatty Liver Disease1Dyslipidaemia1Breast Cancer1Cancer Survivorship1Health Attitude1Gallstone Disease1Bile Duct Diseases1Chronic Kidney Disease stage31Chronic Kidney Disease stage41Diet Habit1Hypercholesterolemia1Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Singapore138
Clinical trials in Australia10

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Hypertension

SponsorTrials
Medtronic Vascular6
ReCor Medical6
Aktiia5
Peking University5
Shanghai Jiao Tong University School of Medicine4
Beijing Friendship Hospital3
Shanghai 10th People's Hospital3
Shenzhen Salubris Pharmaceuticals3
Jing Liu3
Istituto Auxologico Italiano3

Sponsors with the most current trials registered for this condition.

05

Questions about Changi General Hospital trials

How many clinical trials does Changi General Hospital sponsor?

Changi General Hospital is the lead sponsor of 13 current trials on ClinicalTrials.gov in our Singapore and Australia registers, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.

Are Changi General Hospital trials recruiting?

Yes. 8 of its 13 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.